Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 Feb;80(2):102–108. doi: 10.1136/bjo.80.2.102

Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.

B E Damato 1, J Paul 1, W S Foulds 1
PMCID: PMC505399  PMID: 8814738

Abstract

AIMS: The aims of this study were to report local tumour control after trans-scleral local resection of uveal melanoma and to identify risk factors for (i) clinical residual tumour recognised immediately after surgery, and (ii) delayed tumour recurrence from subclinical microscopic deposits. METHODS: The sample included 310 patients, treated by choroidectomy (188), cyclochoroidectomy (87), or iridocyclectomy (35), with follow up ranging from 42 days to 20.9 years (median 36 months), a mean basal largest tumour diameter of 13.2 mm, and a mean tumour thickness of 7.4 mm. RESULTS: There were 24 patients with residual tumour. Forward stepwise logistic regression indicated that posterior extension to within 1 disc diameter of the optic disc or fovea was the sole best indicator of the risk of residual disease (p < 0.001). After excluding these cases, 286 patients were studied for the development of delayed local recurrence, which occurred in 57 cases. Forward stepwise multivariate analysis showed the statistically significant predictors for recurrent tumour to be epithelioid cellularity (p = 0.002), posterior tumour extension to < 1 disc diameter of disc of fovea (p = 0.002), large tumour diameter > or = 16 mm (p = 0.019) and lack of adjunctive plaque radiotherapy (p = 0.018). CONCLUSIONS: The recurrence rate at 4 years varied from 6% if no risk factors were present to 57% if there were more than two risk factors.

Full text

PDF
102

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Char D. H., Quivey J. M., Castro J. R., Kroll S., Phillips T. Helium ions versus iodine 125 brachytherapy in the management of uveal melanoma. A prospective, randomized, dynamically balanced trial. Ophthalmology. 1993 Oct;100(10):1547–1554. doi: 10.1016/s0161-6420(93)31446-6. [DOI] [PubMed] [Google Scholar]
  2. Damato B. E., Foulds W. S. Ciliary body tumours and their management. Trans Ophthalmol Soc U K. 1986;105(Pt 2):257–264. [PubMed] [Google Scholar]
  3. Damato B. E., Paul J., Foulds W. S. Predictive factors of visual outcome after local resection of choroidal melanoma. Br J Ophthalmol. 1993 Oct;77(10):616–623. doi: 10.1136/bjo.77.10.616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Damato B. E., Paul J., Foulds W. S. Risk factors for metastatic uveal melanoma after trans-scleral local resection. Br J Ophthalmol. 1996 Feb;80(2):109–116. doi: 10.1136/bjo.80.2.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Damato B. E. Tumour fluorescence and tumour-associated fluorescence of choroidal melanomas. Eye (Lond) 1992;6(Pt 6):587–593. doi: 10.1038/eye.1992.127. [DOI] [PubMed] [Google Scholar]
  6. Forrest A. W., Keyser R. B., Spencer W. H. Iridocyclectomy for melanomas of the ciliary body: a follow-up study of pathology and surgical morbidity. Ophthalmology. 1978 Dec;85(12):1237–1249. doi: 10.1016/s0161-6420(78)35560-3. [DOI] [PubMed] [Google Scholar]
  7. Foulds W. S., Damato B. E. Low-energy long-exposure laser therapy in the management of choroidal melanoma. Graefes Arch Clin Exp Ophthalmol. 1986;224(1):26–31. doi: 10.1007/BF02144128. [DOI] [PubMed] [Google Scholar]
  8. Foulds W. S. The local excision of choroidal melanomata. Trans Ophthalmol Soc U K. 1973;93(0):343–346. [PubMed] [Google Scholar]
  9. Gragoudas E. S., Seddon J. M., Egan K., Glynn R., Munzenrider J., Austin-Seymour M., Goitein M., Verhey L., Urie M., Koehler A. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology. 1987 Apr;94(4):349–353. doi: 10.1016/s0161-6420(87)33456-6. [DOI] [PubMed] [Google Scholar]
  10. Lommatzsch P. K. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas: 20 years' experience. Br J Ophthalmol. 1986 Nov;70(11):844–851. doi: 10.1136/bjo.70.11.844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Packer S., Stoller S., Lesser M. L., Mandel F. S., Finger P. T. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology. 1992 May;99(5):767–774. doi: 10.1016/s0161-6420(92)31899-8. [DOI] [PubMed] [Google Scholar]
  12. Peyman G. A., Juarez C. P., Diamond J. G., Raichand M. Ten years experience with eye wall resection for uveal malignant melanomas. Ophthalmology. 1984 Dec;91(12):1720–1725. doi: 10.1016/s0161-6420(84)34086-6. [DOI] [PubMed] [Google Scholar]
  13. Shields J. A., Shields C. L., Shah P., Sivalingam V. Partial lamellar sclerouvectomy for ciliary body and choroidal tumors. Ophthalmology. 1991 Jun;98(6):971–983. doi: 10.1016/s0161-6420(91)32194-8. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES